- Title
- Essential medicine selection during the COVID-19 pandemic: Enabling access in uncharted territory
- Creator
- A G Parrish
- Date Issued
- 2020
- Date
- 2020
- Type
- text
- Type
- article
- Identifier
- http://hdl.handle.net/11260/3364
- Identifier
- vital:43319
- Identifier
- http://www.samj.org.za/index.php/samj/article/view/13086
- Description
- The COVID-19 pandemic requires urgent decisions regarding treatment policy in the face of rapidly evolving evidence. In response, the South African Essential Medicines List Committee established a subcommittee to systematically review and appraise emerging evidence, within very short timelines, in order to inform the National Department of Health COVID-19 treatment guidelines. To date, the subcommittee has reviewed 14 potential treatments, and made recommendations based on local context, feasibility, resource requirements and equity. Here we describe the rapid review and evidence-to-decision process, using remdesivir and dexamethasone as examples. Our experience is that conducting rapid reviews is a practical and efficient way to address medicine policy questions under pandemic conditions.
- Format
- 3 pages
- Format
- Publisher
- South African Medical Journal
- Language
- English
- Relation
- South African Medical Journal
- Relation
- S Afr Med J 2020;110(8):753-755. https://doi.org/10.7196/SAMJ.2020.v110i8.14770
- Relation
- South African Medical Journal volume 110 Issue 11 08 09 2020 2020:753-755
- Rights
- © 2020 SAMJ /Author/s
- Rights
- © This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0.
- Hits: 635
- Visitors: 594
- Downloads: 43
Collections
Faculty of Health Sciences
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCE1 | 13086-58569-1-PB.pdf | 165 KB | Adobe Acrobat PDF | View Details Download |